APA (7th ed.) Citation

Bryrup, T., Faurholt-Jepsen, D., Skov, M., Katzenstein, T., Mathiesen, I., Helweg-Larsen, J., . . . Pressler, T. (2024). 52 Specific Pseudomonas aeruginosa IgG levels before and after elexacaftor/tezacaftor/ivacaftor treatment. Journal of Cystic Fibrosis, 23, S28. https://doi.org/10.1016/S1569-1993(24)00895-6

Chicago Style (17th ed.) Citation

Bryrup, T., D. Faurholt-Jepsen, M. Skov, T. Katzenstein, I. Mathiesen, J. Helweg-Larsen, H. Johansen, T. Qvist, and T. Pressler. "52 Specific Pseudomonas Aeruginosa IgG Levels Before and After Elexacaftor/tezacaftor/ivacaftor Treatment." Journal of Cystic Fibrosis 23 (2024): S28. https://doi.org/10.1016/S1569-1993(24)00895-6.

MLA (9th ed.) Citation

Bryrup, T., et al. "52 Specific Pseudomonas Aeruginosa IgG Levels Before and After Elexacaftor/tezacaftor/ivacaftor Treatment." Journal of Cystic Fibrosis, vol. 23, 2024, p. S28, https://doi.org/10.1016/S1569-1993(24)00895-6.